Roche Holding AG (RHHVF)
OTCMKTS · Delayed Price · Currency is USD
464.88
-19.49 (-4.02%)
At close: Nov 5, 2026
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $368.42 billion as of November 5, 2026. Its market cap has increased by 40.82% in one year.
Market Cap
368.42B
Enterprise Value
402.28B
Revenue
77.92B
Global Rank
n/a
Country Rank
n/a
PE Ratio
24.75
ChartMarket Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 368.42B, an increase of 4,106.30%. That is a compound annual growth rate of 11.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 383.86B | 15.79% |
| Dec 30, 2025 | 331.52B | 46.55% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 1.19B |
| Veradigm | 808.86M |
| American Oncology Network | 779.39M |
| Nika Pharmaceuticals | 369.14M |
| CytoDyn | 332.55M |
| Northwest Biotherapeutics | 301.86M |
| Elite Pharmaceuticals | 261.64M |
| Glorywin Entertainment Group | 234.77M |